Coloplast A/S (OTCMKTS:CLPBY) Short Interest Up 504.6% in April

Coloplast A/S (OTCMKTS:CLPBY - Get Free Report) was the target of a significant growth in short interest in April. As of April 30th, there was short interest totalling 92,500 shares, a growth of 504.6% from the April 15th total of 15,300 shares. Based on an average trading volume of 189,400 shares, the short-interest ratio is currently 0.5 days.

Coloplast A/S Stock Performance

OTCMKTS:CLPBY traded down $0.05 during mid-day trading on Friday, hitting $12.28. The stock had a trading volume of 28,837 shares, compared to its average volume of 100,352. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.35 and a current ratio of 0.53. The stock has a market cap of $26.52 billion, a price-to-earnings ratio of 37.25, a PEG ratio of 2.91 and a beta of 0.09. Coloplast A/S has a twelve month low of $9.90 and a twelve month high of $14.34. The company's 50 day simple moving average is $13.23 and its 200 day simple moving average is $12.12.

Coloplast A/S (OTCMKTS:CLPBY - Get Free Report) last released its earnings results on Friday, February 9th. The company reported $0.08 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.08. The company had revenue of $953.60 million for the quarter. Coloplast A/S had a return on equity of 43.30% and a net margin of 19.48%. On average, equities research analysts forecast that Coloplast A/S will post 0.35 earnings per share for the current year.

Coloplast A/S Cuts Dividend

The business also recently disclosed a dividend, which will be paid on Tuesday, May 28th. Investors of record on Monday, May 20th will be issued a $0.0463 dividend. The ex-dividend date is Friday, May 17th. Coloplast A/S's payout ratio is 23.33%.

Coloplast A/S Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.